The NIAID Radiation Countermeasures Program Business Model-Reference-Cited by-同舟云学术

The NIAID Radiation Countermeasures Program Business Model

Published:2010-12 Issue:4 Volume:8 Page:357-363
ISSN:1538-7135
Container-title:Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science
language:en
Short-container-title:Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science

Author:

Hafer Nathaniel¹,Maidment Bert W.¹,Hatchett Richard J.¹

Affiliation:

1. Nathaniel Hafer, PhD, is a Health Scientist, Radiation/Nuclear Medical Countermeasures Development Program, National Institute for Allergy and Infectious Diseases (NIAID), and Science and Technology Policy Fellow, Science and Policy Programs, American Association for the Advancement of Science, Washington, DC. Bert W. Maidment, PhD, is Associate Director for Product Development, National Institutes of Health, NIAID, Division of Allergy, Immunology, and Transplantation, Bethesda, Maryland. Richard J....

Publisher

Mary Ann Liebert Inc

Subject

Management, Monitoring, Policy and Law,Public Health, Environmental and Occupational Health,General Medicine,Health(social science)

Link

http://www.liebertpub.com/doi/pdf/10.1089/bsp.2010.0041

Reference3 articles.

1. NIAID/NIH RADIATION/NUCLEAR MEDICAL COUNTERMEASURES PRODUCT RESEARCH AND DEVELOPMENT PROGRAM

2. Animal Models for Medical Countermeasures to Radiation Exposure

3. 16. Farese AM, Cohen MV, Gibbs AM, et al. Filgrastim administration significantly improves survival in nonhuman primates following a 50% lethal dose of total body irradiation. Radiation Research Society Annual Meeting; Savannah, GA; Poster Session 5.40; October 2009.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapamycin Ameliorates Radiation-Induced Testis Damage in Mice;Frontiers in Cell and Developmental Biology;2022-04-25

2. Scientific research and product development in the United States to address injuries from a radiation public health emergency;Journal of Radiation Research;2021-07-24

3. Setting Strategic Objectives for the Coalition for Epidemic Preparedness Innovations: An Exploratory Decision Analysis Process;INFORMS Journal on Applied Analytics;2019-11

4. Use of Growth Factors and Other Cytokines for Treatment of Injuries During a Radiation Public Health Emergency;Radiation Research;2019-05-13

5. Delayed Captopril Administration Mitigates Hematopoietic Injury in a Murine Model of Total Body Irradiation;Scientific Reports;2019-02-18